Exhibit 23.3
CONSENT OF SMITH, ANGLIN & CO., INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration
Statement (Form S-8) pertaining to Access Pharmaceuticals, Inc. 1995 Stock
Option Plan of our report dated September 21, 1995, with respect to the
consolidated financial statements for Access Pharmaceuticals, Inc. included
in the Annual Report (Form 10-K) for the year ended December 31, 1999, filed
with the Securities and Exchange Commission.
/s/ Smith, Anglin & Co.
Smith, Anglin & Co.
Dallas, Texas
September 11, 2000
